|
Market Closed -
Euronext Dublin
09:25:00 23/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 7.000 EUR | 0.00% |
|
0.00% | -9.09% |
| 26/08 | Malin swings to interim profit as finance income rises and costs fall | AN |
| 26/02 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| Market Cap | 3.03Cr 3.46Cr 2.85Cr 2.61Cr 4.87Cr 331.19Cr 4.91Cr 34Cr 13Cr 168.85Cr 13Cr 13Cr 547.46Cr | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 1.74Cr 1.99Cr 1.64Cr 1.5Cr 2.8Cr 190.4Cr 2.82Cr 20Cr 7.64Cr 97Cr 7.46Cr 7.3Cr 314.74Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 3 months | -5.41% | ||
| 6 months | -9.09% | ||
| Current year | -9.09% |
| 1 week | 6.8 |  | 7 |
| 1 month | 6.8 | | 7 |
| Current year | 6.8 | | 8.45 |
| 1 year | 6.8 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 13.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 01/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 02/08/2019 |
| Director/Board Member | 67 | 16/07/2018 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 16/07/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/06/26 | Exercice | 10,307 | 0.2382% | |||
| 28/05/25 | Exercice | Chief Executive Officer | 5,746 | 0.1328% | ||
| 07/04/25 | Sell | Director | 11,075 | 0.2560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -14.63% | +54.19% | 3.47Cr | |
| -1.64% | +1.16% | +54.09% | +109.07% | 1,04300Cr | |
| -0.01% | +0.71% | +52.44% | +67.71% | 65TCr | |
| -0.05% | +0.98% | +19.08% | +73.55% | 47TCr | |
| -0.25% | +0.19% | +36.95% | +45.63% | 35TCr | |
| +0.98% | +2.91% | +20.59% | +27.91% | 27TCr | |
| -1.91% | +2.42% | +10.41% | +12.53% | 26TCr | |
| -1.01% | +7.90% | +41.59% | +51.70% | 22TCr | |
| -0.85% | +2.50% | +32.32% | +101.80% | 19TCr | |
| -2.53% | -7.47% | -32.63% | -60.67% | 18TCr | |
| Average | -0.21% | +1.27% | +22.02% | +48.34% | 36.33TCr | |
| Weighted average by Cap. | +0.44% | +1.34% | +35.89% | +65.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -69L -78.61L -64.86L -59.3L -1.11Cr -75Cr -1.12Cr -7.79Cr -3.02Cr -38Cr -2.95Cr -2.89Cr -124.48Cr |
| Net Debt | -6.21Cr -7.08Cr -5.84Cr -5.34Cr -9.97Cr -677.76Cr -10Cr -70Cr -27Cr -345.54Cr -27Cr -26Cr -1.12TCr | -1.29Cr -1.47Cr -1.21Cr -1.11Cr -2.07Cr -140.79Cr -2.09Cr -15Cr -5.65Cr -72Cr -5.52Cr -5.4Cr -232.73Cr |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | €7.000 | 0.00% | 0 |
| 22/26/22 | €7.000 | +2.94% | 1 |
| 21/26/21 | €6.800 | 0.00% | 26 |
| 18/26/18 | €6.800 | -2.86% | 141 |
| 17/26/17 | €7.000 | 0.00% | 0 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.000EUR
Average target price
15.50EUR
Spread / Average Target
+121.43%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
